Cargando…

The utility of noninvasive scores in non-alcoholic fatty liver disease patients with normal and elevated serum transaminases

BACKGROUND AND AIM: Noninvasive scores are developed for the estimation of advanced fibrosis, including parameters in addition to transaminases in non-alcoholic fatty liver disease (NAFLD). In this study, we aimed to investigate the diagnostic performances of Fibrosis-4 (FIB-4) and NAFLD Fibrosis Sc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaya, Eda, Bakir, Alev, Eren, Fatih, Yilmaz, Yusuf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kare Publishing 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344368/ https://www.ncbi.nlm.nih.gov/pubmed/35949666 http://dx.doi.org/10.14744/hf.2020.0006

Ejemplares similares

Simple Noninvasive Scores Are Clinically Useful to Exclude, Not Predict, Advanced Fibrosis: A Study in Turkish Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease
por: Kaya, Eda, et al.
Publicado: (2020)

Elevated levels of alanine transaminase and triglycerides within normal limits are associated with fatty liver
por: TOMIZAWA, MINORU, et al.
Publicado: (2014)

Alcohol-Related Elevation of Liver Transaminase Is Associated With Gut Microbiota in Male
por: Jiao, Mengfan, et al.
Publicado: (2022)

The comparison of resting metabolic rate between biopsy-proven non-alcoholic steatohepatitis and non-alcoholic fatty liver patients
por: Kenger, Emre Batuhan, et al.
Publicado: (2020)

Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease
por: Kaya, Eda, et al.
Publicado: (2022)

Elevated transaminases and hepatomegaly in an obese diabetic.
Publicado: (1983)

Prevalence of metabolic dysfunction-associated fatty liver disease in kidney transplant recipients: A cross-sectional study using FibroScan
por: Yesil, Ezgi Ersoy, et al.
Publicado: (2023)

Insidious danger for young adults: Metabolic (dysfunction)-associated fatty liver disease
por: Kaya, Eda, et al.
Publicado: (2022)

The role of FibroScan in the era of metabolic (dysfunction)-associated fatty liver disease
por: Yilmaz, Yusuf, et al.
Publicado: (2023)

Metabolic-associated Fatty Liver Disease (MAFLD): A Multi-systemic Disease Beyond the Liver
por: Kaya, Eda, et al.
Publicado: (2022)

Noninvasive assessment of liver fibrosis with the aspartate transaminase to platelet ratio index (APRI): Usefulness in patients with chronic liver disease: APRI in chronic liver disease
por: Yilmaz, Yusuf, et al.
Publicado: (2011)

The Effect of Berberis Vulgaris Extract on Transaminase Activities in Non-Alcoholic Fatty Liver Disease
por: Iloon Kashkooli, Raziye, et al.
Publicado: (2015)

Remdesivir: Elevated transaminase level: case report
Publicado: (2022)

Favipiravir: Erythema and transaminase elevation: case report
Publicado: (2022)

Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI)
por: Adler, Michael
Publicado: (2011)

Elevations in Liver Transaminases in COVID-19: (How) Are They Related?
por: Pott-Junior, Henrique, et al.
Publicado: (2021)

Elevated Transaminases as Predictors of COVID-19 Pneumonia Severity
por: Radonjić, Tijana, et al.
Publicado: (2022)

A newly noninvasive model for prediction of non-alcoholic fatty liver disease: utility of serum prolactin levels
por: Zhang, Pengzi, et al.
Publicado: (2019)

Etiology and Pathogenesis of Marked Elevation of Serum Transaminase in Patients With Acute Gallstone Disease
por: Isogai, Masatoshi, et al.
Publicado: (1991)

Elevation of Serum Transaminase Levels Due to Favipiravir Use in the Treatment of COVID-19
por: Bayram, Mehmet, et al.
Publicado: (2021)

Prevalence of elevated liver transaminases and their relationship with alcohol use in people living with HIV on anti-retroviral therapy in Uganda
por: Freiman, J. Morgan, et al.
Publicado: (2021)

Mushroom Poisoning Presenting With Acute Kidney Injury and Elevated Transaminases
por: Beaumier, Mathilde, et al.
Publicado: (2019)

Effect of Non-alcoholic Fatty Liver Disease on Transaminase Levels and Transient Elastography in Patients with Chronic Hepatitis B
por: Sharif, Asim, et al.
Publicado: (2019)

Correction to: A newly noninvasive model for prediction of non-alcoholic fatty liver disease: utility of serum prolactin levels
por: Zhang, Pengzi, et al.
Publicado: (2020)

Diagnostic accuracy of liver stiffness measurement in chronic hepatitis B patients with normal or mildly elevated alanine transaminase levels
por: Li, Qiang, et al.
Publicado: (2018)

Hepatitis E Virus infection in HIV-infected patients with elevated serum transaminases levels
por: Sellier, Pierre, et al.
Publicado: (2011)

Transplantation of Deceased Donor Livers With Elevated Levels of Serum Transaminases at Shiraz Transplant Center
por: Fakhar, Nasir, et al.
Publicado: (2016)

Post-Embolization Syndrome Complicated by Hypertensive Emergency and Severely Elevated Transaminases
por: Kashfi, Simon, et al.
Publicado: (2021)

Elevated transaminases and hypoalbuminemia in Covid-19 are prognostic factors for disease severity
por: Wagner, Jason, et al.
Publicado: (2021)

Idiopathic adulthood ductopenia with elevated transaminase only: A case report
por: Zhang, Xiao-Chen, et al.
Publicado: (2020)

The Effect of Elevated Alanine Transaminase on Non-invasive Prenatal Screening Failures
por: Chen, Ping, et al.
Publicado: (2022)

Serum Progranulin as an Independent Marker of Liver Fibrosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease
por: Yilmaz, Yusuf, et al.
Publicado: (2011)

Patients with Non-Alcoholic Fatty Liver Disease and Alcohol Dehydrogenase 1B/Aldehyde Dehydrogenase 2 Mutant Gene Have Higher Values of Serum Alanine Transaminase
por: Chien, Tsuo-Hsuan, et al.
Publicado: (2023)

Eyeing non-alcoholic fatty liver disease: The noninvasive way
por: Gude, Dilip
Publicado: (2011)

Chitosan promotes immune responses, ameliorates glutamic oxaloacetic transaminase and glutamic pyruvic transaminase, but enhances lactate dehydrogenase levels in normal mice in vivo
por: YEH, MING-YANG, et al.
Publicado: (2016)

Multiple drugs: Elevated alanine transaminase and off label use: case report
Publicado: (2020)

Baricitinib/lopinavir/ritonavir: Elevated transaminases and off-label use: case report
Publicado: (2020)

Azithromycin: Elevated transaminase levels during off-label treatment: case report
Publicado: (2021)

Parental metabolic syndrome and elevated liver transaminases are risk factors for offspring, even in children and adolescents with a normal body mass index
por: Song, Kyungchul, et al.
Publicado: (2023)

Noninvasive Imaging for the Evaluation of Non-Alcoholic Fatty Liver Disease Spectrum
por: Liu, Qianjiao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_96ja2rgvedrugveil3vdd54o3h